Special Webinar on N of 1 | Access | Innovation co hosted by Biogen
36 minutes
n-Lorem Foundation, ChemGenes Announce Collaboration to Support Manufacturing of Individualized Treatments for Patients with Ultra-Rare Diseases
Foundation’s partnership with [...]
Nonclinical Testing of Individualized Antisense Oligonucleotide Drug Products for Severely Debilitating or Life-Threatening Diseases
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Download PDF
n-Lorem Foundation Partners with Ultragenyx to Bolster Development of Personalized Medicines for Patients with Ultra-Rare Diseases
Foundation’s collaboration with [...]
Antisense Technology: An Overview and Prospectus
Crooke, S.T., Baker, B.F., Crooke R.M., Liang, X.H.
